SRPT

Sarepta Therapeutics Inc — AI technical analysis, September 2026
NYSE/NASDAQ · Biotechnology
AI Recommendation
HOLD
Technical score 15/100
Last price: $20.72  ·  52W range $14.68 – $25.32
Short answer

Should you buy SRPT right now? Stockgaide's AI rates SRPT as HOLD, with a technical score of 15/100 at a last price of $20.72. The 50-day average is below the 200-day average, and RSI sits at 61.7. Wall Street's consensus rating is 2.55/5.

Full AI analysis for SRPT

Technical signal details

Rule-based read from price and momentum indicators only — the score behind the AI's recommendation above. Technical score: 15/100 (SELL).

Technical indicators

RSI (14)
61.7
SMA 50
18.52
SMA 200
19.27
MACD hist
-0.136

Fundamentals & Wall Street

Market Cap
$2.21B
P/E (TTM)
Dividend Yield
Analyst Consensus
2.55 / 5

Analyst ratings: 14 Buy · 13 Hold · 6 Sell (1 = Strong Buy, 5 = Strong Sell)

SRPT stock: frequently asked questions

Is SRPT a buy right now?

Stockgaide's AI currently rates SRPT as HOLD, with a technical score of 15 out of 100 at a last price of $20.72. This is educational content, not investment advice.

Is SRPT in an uptrend?

SRPT's 50-day moving average (18.52) is below its 200-day moving average (19.27), which points to a medium-term downtrend.

What is SRPT's RSI today?

SRPT has a 14-day RSI of 61.7, which places it in neutral territory (above 70 is overbought, below 30 is oversold).

What do analysts say about SRPT?

Wall Street analysts covering SRPT have a consensus rating of 2.55 out of 5 (1 = Strong Buy), meaning they are neutral — 14 Buy · 13 Hold · 6 Sell.

Where is SRPT trading in its 52-week range?

SRPT last traded at $20.72, against a 52-week range of $14.68 to $25.32 — about 57% of the way up that range.

Get the full AI analysis of SRPT

Price targets, fundamentals deep-dive and an AI-written report — free, no signup.

Analyze SRPT now →
Data updated Sep 15, 2026 · refreshed daily